Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q1 EPS, Revenues Beat

Go back to Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q1 EPS, Revenues Beat
(NASDAQ: XERS) Delayed: 8.65 +0.32 (3.84%)
Previous Close $8.33    52 Week High
Open $8.33    52 Week Low
Day High $8.67    P/E N/A 
Day Low $8.25    EPS
Volume 570,469